Frontlight ResearchEarly access
Trial site
Perelman School of Medicine at the University of Pennsylvania
- 3running trials
The trials here
What the 3 trials at this site are about, from their registry records.
- Conditions
- Ovarian cancer2 trials
- Endometrial cancer1 trial
- Schizophrenia1 trial
- Phase
- Phase 1/21 trial
- Phase 2/31 trial
- Status
- Recruiting3 trials
- Lead sponsor
- Bristol-Myers Squibb1 trial
- Daiichi Sankyo1 trial
- Regeneron Pharmaceuticals1 trial
Running trials
Recruiting
Effectiveness and Adverse-effect Switch Evaluation of Xanomeline and Trospium Chloride (KarXT)
Recruiting
Recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Ovarian cancer2 recruiting
- Endometrial cancer1 recruiting
- Schizophrenia1 recruiting
Site data: ClinicalTrials.govUpdated 12 Nov 2026